GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

depemokimab   Click here for help

GtoPdb Ligand ID: 14305

Synonyms: depemokimab-ulaa | Exdensur® | GSK-3511294 | GSK3511294
Approved drug Immunopharmacology Ligand
depemokimab is an approved drug
Compound class: Antibody
Comment: Depemokimab (GSK-3511294) is a humanized IgG1κ monoclonal; antibody that targets interleukin 5 (IL-5). It binds to the same epitope as, but with higher affinity mepolizumab [4].
No information available.
Summary of Clinical Use Click here for help
Depemokimab was approved by the UK MHRA and US FDA in December 2025, as an add-on maintenance therapy in the treatment of severe eosinophilic asthma [1].